-Reuters Citing Ukrainian Officials
aTyr Pharma Presents Poster Demonstrating Preclinical Effects Of Efzofitimod In Rheumatoid Arthritis And Rheumatoid Arthritis-Associated ILD At The ACR Convergence 2023
aTyr Pharma, Inc. (NASDAQ:LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced a poster